Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ATP Announces Nine Month Earnings.


Business Editors

SAN ANTONIO--(BUSINESS WIRE)--Aug. 14, 2001

Advanced Tobacco Products Inc., d/b/a Advanced Therapeutic Products Inc. ("ATP ATP: see adenosine triphosphate.
ATP
 in full adenosine triphosphate

Organic compound, substrate in many enzyme-catalyzed reactions (see catalysis) in the cells of animals, plants, and microorganisms.
") (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:AVTH) today reported after tax earnings of $411,533 (5 cents per share Cents per share

The amount of a mutual fund's dividend or capital gains distributions that a shareholder will receive for each share owned.
) on operating revenues of $501,304 for the nine month period ending June 30, 2001, as compared to $359,262 (4 1/2 cents per share) on operating revenues of $388,724 for the nine month period ending June 30, 2000.

In 1987, ATP sold its patented nicotine technology, which forms the basis of the Nicorette(R)/Nicotrol(R) Inhaler inhaler /in·hal·er/ (in-hal´er)
1. an apparatus for administering vapor or volatilized medications by inhalation.

2. ventilator (2).


in·hal·er
n.
, to what is now Pharmacia Corporation ("Pharmacia"), in exchange for product payments of 3% of Pharmacia's net sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
.

In September, 1998, Pharmacia launched the Nicotrol(R) Inhaler nationwide in the U.S. as a prescription product. In addition, the Nicorette(R) Inhaler is sold primarily as an over-the-counter product in 16 European countries, in addition to Russia, Mexico, Australia, New Zealand, Hong Kong, Singapore and Taiwan. ATP understands that additional country launches are planned by Pharmacia as regulatory approvals are granted.

The Nicorette(R)/Nicotrol(R) Inhaler is the only nicotine replacement product that is designed to help control a smoker's cravings for cigarettes while providing a key behavioral component of smoking -- the hand-to-mouth ritual.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 14, 2001
Words:210
Previous Article:First Aviation Services Inc. Closes the Acquisition of Superior's Regional Distribution Centers.
Next Article:Starwire Appoints Robin Pou as Chief Operations Officer.
Topics:



Related Articles
Antidote for a heart stopper.
Air Force to Select Advanced Targeting Pod.
The Zylux Rapid Hygiene System for Measuring Cleanliness.
NIST AWARDS ZYVEX TEAM $25M CONTRACT FOR NANOTECHNOLOGY.
NOTEBOOK: FERREIRA, CLEMENT HAVE NO TROUBLE SEEDED PLAYERS BREEZE THANKS TO SERVES.
NOTEBOOK: ROUX MAKES HIS MARK.
WILL ATP SNUB L.A? MARQUEE PLAYERS MIGHT SKIP FUTURE MERCEDES CUPS.
EDBERG: HAPPY RETIREE AT AGE 31.
TENNIS: PHILIPPOUSSIS WILL FACE DELIC IN CHALLENGER FINAL.
TENNIS: PHILIPPOUSSIS WINS CHALLENGER FINAL.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles